New Protocols Rejuvenate Epi-On Cross-Linking
Clinical trials evaluate the safety and efficacy of epithelium-off corneal collagen cross-linking treatment protocols with supplemental oxygen
Michael B. Raizman |
Epithelium-off (epi-off) CXL has been effective in halting the progression of keratoconus, offering hope to many patients with this progressive condition (1). Epithelium-on (epi-on) CXL, in which the epithelium is minimally disturbed, has historically not been as successful (2).
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine